💚 Health & Wellness · Monthly Roundup
March 2026
March 2026 was a month defined by the collision of technology and trust in health and medicine. From AI chatbots dispensing questionable medical advice to a Harris Poll documenting an entrenched online misinformation crisis, the reliability of health information emerged as a central anxiety for patients, clinicians, and policymakers alike. At the same time, concrete clinical progress arrived in the form of promising findings on long COVID fatigue treatment and kidney stone prevention, offering a counterweight to the month's more cautionary headlines. Beneath it all ran a persistent thread of health equity, surfacing in data on teen obesity, maternal mortality, and the uneven reach of opioid-use disorder programs.
Trends
The dominant trend of the month was a widening crisis of medical trust and information quality. Two major stories — the NPR investigation into ChatGPT's medical accuracy and the Harris Poll on health misinformation — converged on the same conclusion: the information environments Americans rely on for health decisions are increasingly unreliable, and the consequences are measurable. A second clear pattern was the persistence of health inequity as both cause and effect across multiple conditions, with maternal mortality data, teen obesity figures, and opioid treatment outcomes all revealing that education, income, and access to wraparound care remain among the strongest predictors of health outcomes in the United States. Finally, the month signaled a maturing of AI's role in pharmaceutical development, with the Eli Lilly–Insilico Medicine deal illustrating how seriously major industry players now regard algorithm-driven drug discovery, even as questions about AI's safety in consumer-facing health applications grew louder.
Looking Ahead
The University of Kent meningitis outbreak will warrant close monitoring in April, particularly as health authorities assess whether antibiotic distribution successfully contained transmission and whether similar vulnerabilities exist at other densely populated campuses. The long COVID antidepressant findings from McMaster University are likely to generate follow-up clinical guidance from major health bodies, and clinicians should watch for updated treatment protocols in the coming weeks. The Insilico–Lilly deal also sets a precedent that may accelerate further AI-pharma partnerships, making April a pivotal month for tracking how the industry responds to what is now one of the largest AI drug development commitments on record.
Top Stories
The ten most consequential health and wellness stories of March 2026 span infectious disease, mental health, addiction medicine, AI in healthcare, and the social determinants that continue to shape who gets well and who does not.
NPR Health
ChatGPT might give you bad medical advice, studies warn
New research raises fresh concerns about AI chatbots like ChatGPT delivering inaccurate or misleading medical guidance to users. The accuracy of health information varies significantly based on how questions are framed, putting less tech-savvy users at a disadvantage. As millions turn to AI for health answers, the findings underscore the danger of treating these tools as a substitute for professional medical advice.
Read →Guardian Health
Two dead and 11 seriously ill in meningitis outbreak at University of Kent
A serious meningitis outbreak at the University of Kent has killed two people and left 11 others critically ill, with health authorities confirming 13 cases of invasive meningococcal disease. The UK Health Security Agency has moved swiftly to distribute antibiotics to students in the Canterbury area to contain the spread. Meningococcal disease, which combines meningitis and blood poisoning, can progress rapidly and prove fatal within hours of symptoms appearing.
Read →NPR Health
As parents clamor for a treatment touted for autism, doctors hesitate to prescribe it
Leucovorin, a prescription folate derivative, has gained a fervent following among families seeking autism treatments despite limited clinical evidence supporting its use. Physicians find themselves caught between scientific caution and the risk of alienating patients who may turn to less reputable sources if refused. The situation highlights a persistent tension in medicine between patient demand and evidence-based practice.
Read →Medical Xpress
Concerning rise in US teen obesity over a decade
Nearly one in five American teenagers is now classified as obese, a figure that has climbed steadily over the past decade and signals a looming public health crisis. The consequences extend well beyond adolescence, with obesity at this stage linked to diabetes, hypertension, sleep apnea, and serious mental health challenges. Gaps in data on how teens are actually attempting to manage their weight continue to hamper the development of targeted clinical and policy interventions.
Read →Medical Xpress
Largest study of its kind tests hydration strategy for kidney stones
A landmark clinical trial from the Urinary Stone Disease Research Network has put a structured hydration behavioral program to the test as a prevention strategy for kidney stone recurrence. With kidney stones striking one in 11 Americans — and nearly half facing a repeat episode — the stakes for finding an effective intervention are high. The findings could reshape how clinicians approach one of medicine's most painful and costly recurring conditions.
Read →Medical Xpress
Recovery-oriented program at may significantly improve quality of life for people with opioid-use disorder
A new study in the *Journal of Addiction Medicine* finds that UTHealth Houston's HEROES program significantly improves treatment retention and quality of life for people with opioid-use disorder. Notably, the community-based model showed strong results even among patients facing compounding barriers like homelessness, lack of insurance, and prior overdose. The findings suggest that recovery-oriented, wraparound care can reach populations that traditional treatment programs routinely fail to serve.
Read →Medical Xpress
U.S. medicine, science facing an online misinformation siege, poll concludes
A new Harris Poll reveals that Americans are increasingly ensnared in a cycle of medical and scientific misinformation spread through social media — and many users are actively amplifying it. The findings underscore a deepening credibility crisis for institutions that depend on public trust to function. As false health claims outpace corrections online, the real-world consequences for policy, behavior, and patient outcomes continue to grow.
Read →Stat News
STAT+: AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion
Eli Lilly has struck a commercialization agreement with AI-driven drug developer Insilico Medicine, putting $115 million on the table upfront and up to $2.75 billion in milestone payments. The deal represents one of the larger bets a major pharma company has placed on AI-generated drug candidates. For Insilico, the partnership signals growing industry confidence in its platform's ability to move molecules from algorithm to clinic.
Read →Medical Xpress
Common antidepressant eases fatigue associated with long COVID, study finds
A large-scale study co-led by McMaster University found that a common antidepressant can significantly reduce fatigue in long COVID patients, marking one of the first medications proven effective against the condition's most debilitating symptoms. The finding carries considerable weight for the estimated millions worldwide still contending with persistent post-infection illness. Researchers say the results open a concrete treatment pathway where few have previously existed.
Read →Medical Xpress
Deaths of white women with no higher education largely driving rising maternal mortality
Maternal mortality in the U.S. is rising sharply among white women without a college degree, narrowing a long-documented racial gap — though not for the better. New research from University of Michigan, Harvard, and the National Association to Advance Black Birth finds that while mortality rates have declined for college-educated Black women, they continue to climb for less-educated Black women and for both Black and white women giving birth at older ages. The findings underscore that education and socioeconomic status are powerful predictors of maternal survival, cutting across racial lines.
Read →Browse by Day
Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →